Search Result "hypodopaminergia"
Hypodopaminergia and âPrecision Behavioral Managementâ (PBM): It is a Generational Family Affair
Journal: Current Pharmaceutical Biotechnology
Volume: 21 Issue: 6 Year: 2020 Page: 528-541
Author(s): Lyle Fried,Edward J. Modestino,David Siwicki,Lisa Lott,Panayotis K. Thanos,David Baron,Rajendra D. Badgaiyan,Jessica V. Ponce,James Giordano,William B. Downs,Marjorie C. Gondré-Lewis,Steinberg Bruce,Eric R. Braverman,Brent Boyett,Kenneth Blum
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) during Adolescent Brain Development
Journal: Current Psychopharmacology
Volume: 10 Issue: 3 Year: 2021 Page: 181-196
Author(s): Kenneth Blum,Abdalla Bowirrat,Marjorie C.G. Lewis,Thomas A. Simpatico,Mauro Ceccanti,Bruce Steinberg,Edward J. Modestino,Panayotis K. Thanos,David Baron,Thomas McLaughlin,Raymond Brewer,Rajendra D. Badgaiyan,Jessica V. Ponce,Lisa Lott,Mark S. Gold
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The âHoly Grailâ in Genetic Addiction Risk Testing
Journal: Current Psychopharmacology
Volume: 9 Issue: 1 Year: 2020 Page: 7-21
Author(s): Kenneth Blum,David Baron,Lisa Lott,Jessica V. Ponce,David Siwicki,Brent Boyett,Bruce Steinberg,Edward J. Modestino,Lyle Fried,Mary Hauser,Thomas Simpatico,Bill W. Downs,Thomas McLaughlin,Raju Hajela,Rajendra D. Badgaiyan
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia
Journal: Current Psychopharmacology
Volume: 9 Issue: 3 Year: 2020 Page: 164-184
Author(s): Raymond Brewer,Kenneth Blum,Abdalla Bowirrat,Edward J. Modestino,David Baron,Rajendra D. Badgaiyan,Mark Moran,Brent Boyett,Mark S. Gold
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Journal: Current Psychopharmacology
Volume: 10 Issue: 2 Year: 2021 Page: 86-97
Author(s): Kenneth Blum,Edward J. Modestino,David Baron,Raymond Brewer,Panayotis Thanos,Igor Elman,Rajendra D. Badgaiyan,B. William Downs,Debasis Bagchi,Thomas McLaughlin,Abdalla Bowirrat,A. Kenison Roy,Mark S. Gold
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1)Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways:Implications for Suicidal Ideation and Substance Use Disorder
Journal: Current Neuropharmacology
Volume: 23 Issue: 8 Year: 2025 Page: 974-995
Author(s): Mark S. Gold,John Wesson Ashford,Panayotis K. Thanos,Gene Jack Wang,Jean Lud Cadet,Eliot L. Gardner,Jag H. Khalsa,Eric R. Braverman,Catherine A. Dennen,Edward J. Modestino,Paul R. Carney,Rossano Kepler Alvim Fiorelli,Aryeh R. Pollack,Rajendra D. Badgaiyan
Preface [Hot topic: Pharmacological Treatment of Schizophrenia: Recent Antipsychotic Drugs and New Therapeutic Strategies Guest Editor: Maria Augusta Raggi ]
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2004 Page: i-i
Author(s): Maria Augusta Raggi
Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Journal: Current Psychiatry Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 111-119
Author(s): Stephan C. Mann, Stanley N. Caroff, Gabor S. Ungvari, E. Cabrina Campbell
D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1068-1088
Author(s): John H. Kehne, Terrance H. Andree, Julia N. Heinrich
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment
Journal: Current Signal Transduction Therapy
Volume: 8 Issue: 2 Year: 2013 Page: 119-128
Author(s): Felice Iasevoli,Livia Avvisati,Gianmarco Latte,Elisabetta F. Buonaguro,Carmine Tomasetti,Luigi Aloj,Andrea de Bartolomeis